Market Tracker

10/22 6:06pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

During the Trading Day
11.66 -0.13 / -1.10%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.66 0.00 / 0.00%
 
Volume: 9.8K

Today’s Trading

Previous close11.79
Today’s open11.80
Day’s range11.61 - 11.99
Volume2,551,753
Average volume (3 months)5,528,051
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+46.79%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book97.06

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.14-2.53%
THRXTheravance Inc-1.66-8.91%
--Cosmo Pharmaceutical...-11.95-6.38%
WXWuxi Pharmatech Caym...-0.13-0.36%
Data as of 4:03pm ET, 10/22/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts